MHRA plans antidepressant label changes after review of suicide and sexual dysfunction warnings
The UK Medicines and Healthcare products Regulatory Agency announced on 15 October 2026 new measures to make antidepressant risk information clearer, covering suicidal thoughts and behaviours and persistent sexual dysfunction.




